Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,968,550
  • Shares Outstanding, K 32,751
  • Annual Sales, $ 2,236 M
  • Annual Income, $ -9,750 K
  • EBIT $ 166 M
  • EBITDA $ 225 M
  • 60-Month Beta 0.78
  • Price/Sales 1.32
  • Price/Cash Flow 14.75
  • Price/Book 2.46

Options Overview Details

View History
  • Implied Volatility 14.19% ( -3.71%)
  • Historical Volatility 16.42%
  • IV Percentile 19%
  • IV Rank 41.41%
  • IV High 27.88% on 11/11/24
  • IV Low 4.52% on 12/21/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 2,677
  • Put/Call OI Ratio 4.35
  • Today's Open Interest 68,247
  • Open Int (30-Day) 49,222

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.07
  • Number of Estimates 7
  • High Estimate 1.14
  • Low Estimate 1.00
  • Prior Year 0.94
  • Growth Rate Est. (year over year) +13.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.81 +2.61%
on 11/19/24
97.89 -6.91%
on 11/06/24
-6.10 (-6.27%)
since 10/25/24
3-Month
88.81 +2.61%
on 11/19/24
98.11 -7.12%
on 08/30/24
-6.78 (-6.92%)
since 08/27/24
52-Week
88.81 +2.61%
on 11/19/24
98.95 -7.91%
on 07/26/24
-2.96 (-3.15%)
since 11/27/23

Most Recent Stories

More News
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys

The Justice Department is suing to block UnitedHealth Group’s $3.3 billion purchase of Amedisys

AMED : 91.35 (+0.36%)
$SPX : 6,004.38 (-0.29%)
$DOWI : 44,934.79 (+0.17%)
$IUXX : 20,702.68 (-1.05%)
UNH : 613.32 (+1.08%)
Stock market today: Wall Street drifts lower as the Trump trade cools

U.S. stocks slipped as juice ran out for the torrid “Trump trade” that swept Wall Street following Donald Trump’s presidential victory

HUM : 294.97 (-0.21%)
NVDA : 132.88 (-2.95%)
AMED : 91.35 (+0.36%)
CI : 338.03 (+0.90%)
JPM : 250.61 (+0.26%)
$SPX : 6,004.38 (-0.29%)
LYV : 139.75 (+0.63%)
$DOWI : 44,934.79 (+0.17%)
$IUXX : 20,702.68 (-1.05%)
TSN : 64.32 (+0.80%)
UNH : 613.32 (+1.08%)
Amedisys: Q3 Earnings Snapshot

Amedisys: Q3 Earnings Snapshot

AMED : 91.35 (+0.36%)
Amedisys Reports Third Quarter 2024 Financial Results

AMED : 91.35 (+0.36%)
Is DaVita Stock Outperforming the Dow?

Although DaVita has outperformed the Dow Jones Industrials Average, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

AMED : 91.35 (+0.36%)
$DOWI : 44,934.79 (+0.17%)
DVA : 167.66 (-0.18%)
Amedisys: Q2 Earnings Snapshot

Amedisys: Q2 Earnings Snapshot

AMED : 91.35 (+0.36%)
Chewy, Blackrock fall; Spirit AeroSystems, Amedisys rise, Monday, 7/1/2024

Stocks that traded heavily or had substantial price changes on Monday: Chewy, Blackrock fall; Spirit AeroSystems, Amedisys rise

KKR : 161.69 (+0.26%)
EQT : 45.10 (-1.01%)
FANG : 177.93 (+1.11%)
CEG : 253.28 (-5.04%)
BLK : 1,029.53 (+0.30%)
SPR : 32.43 (+0.25%)
CHWY : 33.41 (-1.88%)
AMED : 91.35 (+0.36%)
Amedisys: Q1 Earnings Snapshot

Amedisys: Q1 Earnings Snapshot

AMED : 91.35 (+0.36%)
Amedisys: Q4 Earnings Snapshot

Amedisys: Q4 Earnings Snapshot

AMED : 91.35 (+0.36%)
Amedisys: Q3 Earnings Snapshot

Amedisys: Q3 Earnings Snapshot

AMED : 91.35 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure,...

See More

Key Turning Points

3rd Resistance Point 92.33
2nd Resistance Point 91.80
1st Resistance Point 91.41
Last Price 91.35
1st Support Level 90.50
2nd Support Level 89.97
3rd Support Level 89.58

See More

52-Week High 98.95
Fibonacci 61.8% 95.07
Fibonacci 50% 93.88
Fibonacci 38.2% 92.68
Last Price 91.35
52-Week Low 88.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar